Literature DB >> 17556562

Smallpox vaccine. A tame virus runs amok.

Jocelyn Kaiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17556562     DOI： 10.1126/science.316.5830.1418

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   63.714


× No keyword cloud information.
  9 in total

1.  Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.

Authors:  Sophie Duraffour; Graciela Andrei; Dimitri Topalis; Marcela Krečmerová; Jean-Marc Crance; Daniel Garin; Robert Snoeck
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  KAY-2-41, a novel nucleoside analogue inhibitor of orthopoxviruses in vitro and in vivo.

Authors:  Sophie Duraffour; Robert Drillien; Kazuhiro Haraguchi; Jan Balzarini; Dimitri Topalis; Joost J van den Oord; Graciela Andrei; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

3.  A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis.

Authors:  Cheng-Yen Huang; Tsai-Yi Lu; Chi-Horng Bair; Yuan-Shau Chang; Jeng-Kuan Jwo; Wen Chang
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

4.  Study of camelpox virus pathogenesis in athymic nude mice.

Authors:  Sophie Duraffour; Patrick Matthys; Joost J van den Oord; Tim De Schutter; Tania Mitera; Robert Snoeck; Graciela Andrei
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

5.  Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys.

Authors:  Yali Chen; Adams Amantana; Shanthakumar R Tyavanagimatt; Daniela Zima; X Steven Yan; Gopi Kasi; Morgan Weeks; Melialani A Stone; William C Weimers; Peter Samuel; Ying Tan; Kevin F Jones; Daniel R Lee; Shirley S Kickner; Bradley M Saville; Martin Lauzon; Alan McIntyre; Kady M Honeychurch; Robert Jordan; Dennis E Hruby; Janet M Leeds
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.752

6.  Polycyclic N-benzamido imides with potent activity against vaccinia virus.

Authors:  Eva Torres; María D Duque; Pelayo Camps; Lieve Naesens; Teresa Calvet; Mercè Font-Bardia; Santiago Vázquez
Journal:  ChemMedChem       Date:  2010-12-03       Impact factor: 3.540

7.  Variola virus F1L is a Bcl-2-like protein that unlike its vaccinia virus counterpart inhibits apoptosis independent of Bim.

Authors:  B Marshall; H Puthalakath; S Caria; S Chugh; M Doerflinger; P M Colman; M Kvansakul
Journal:  Cell Death Dis       Date:  2015-03-12       Impact factor: 8.469

8.  Ethacrynic and alpha-lipoic acids inhibit vaccinia virus late gene expression.

Authors:  Martina Spisakova; Zdenek Cizek; Zora Melkova
Journal:  Antiviral Res       Date:  2008-12-04       Impact factor: 5.970

9.  One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge.

Authors:  Wenbo Yu; Qing Fang; Weijun Zhu; Haibo Wang; Po Tien; Linqi Zhang; Zhiwei Chen
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.